News - Page 217 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Cybin Announces CDN$20 Million Bought Deal Offering

Cybin Announces CDN$20 Million Bought Deal Offering

Post published:January 18, 2021
Post category:Press Release

Read more about the article Nakul Raval, Researcher at the Neurobiology Research Unit, Copenhagen University Hospital

Nakul Raval, Researcher at the Neurobiology Research Unit, Copenhagen University Hospital

Post published:January 16, 2021
Post category:Interview

Read more about the article Optimi Health Corp. Receives Health Canada Psychedelic Research Exemption and Files Preliminary Prospectus for Initial Public Offering of Units

Optimi Health Corp. Receives Health Canada Psychedelic Research Exemption and Files Preliminary Prospectus for Initial Public Offering of Units

Post published:January 15, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Psychedelics Companies Embrace Tech; MindMed to Study LSD Microdosing; UFC Eyes Psychedelics

Psychedelic Bulletin: Psychedelics Companies Embrace Tech; MindMed to Study LSD Microdosing; UFC Eyes Psychedelics

Post published:January 15, 2021
Post category:Psychedelic Bulletin

Read more about the article Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder

Awakn Life Sciences Appoints CRO to Conduct Phase II Study of MDMA as a Treatment for Alcohol Use Disorder

Post published:January 15, 2021
Post category:Press Release

Read more about the article James Kuo, CEO and Co-founder of Tryp Therapeutics

James Kuo, CEO and Co-founder of Tryp Therapeutics

Post published:January 15, 2021
Post category:Interview

Numinus Announces Grant of Stock Options

Post published:January 14, 2021
Post category:Press Release

Read more about the article CBDV Begins Research on Psilocybin with Section 56 Exemption from Health Canada

CBDV Begins Research on Psilocybin with Section 56 Exemption from Health Canada

Post published:January 14, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

Mydecine Innovations Group Announces C$10 Million Bought Deal Offering of Units

Post published:January 14, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.

Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.

Post published:January 14, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.